South Korea is a "key market" in Covidien's global strategy

August 27, 2013 by Arezu Sarvestani

Covidien launches a $21 million innovation center in South Korea, a country the medical device giant calls key to its international plans.

Covidien launches $21M R&D center in South Korea

Massachusetts medical device maker Covidien (NYSE:COV) is opening the doors on a new Center of Innovation in South Korea, a country that the company calls "a key market in our global strategy."

Covidien plans to spend $21 million over the course of 3 years to support the center, which will focus on engaging local healthcare professionals in design and development of medical devices in order to tailor solutions for the market.

Sign up to get our free newsletters delivered right to your inbox.

Covidien has made other recent moves in the region, including 2 memorandums of understanding signed with the Korean Surgical Society and the Korean Society for Thoracic & Cardiovascular Surgery. All members of both groups will undergo mandatory certification at the new Covidien innovation center.

The facility is more than 6,000 square meters in size with an 11-station surgical lab, an ICU lab with a human patient simulator and a 112-person-capacity auditorium with 3D and high-definition display technology.

Comments